AI-generated from publicly available materials.Hope Care, a digital health innovator from Portugal, has successfully raised €6 million in a Series A funding round aimed at enhancing its remote patient monitoring services throughout Europe.
The funding round was spearheaded by Iberis Capital, with contributions from Vieira de Matos – VDM Capital, S.A., and existing investor Buenavista Equity Partners. José Paulo Carvalho, the CEO, emphasized that this funding represents a pivotal moment for the company, which has spent over a decade collaborating with healthcare institutions to develop a regulated platform that delivers tangible benefits for patients and healthcare systems alike. The investment will facilitate Hope Care's expansion into new European markets.
Founded in 2012, Hope Care has created OpMA, a platform that integrates medical device data, patient-reported outcomes, and clinical workflows. This technology allows healthcare organizations to implement and scale digital care programs for chronic conditions, promoting proactive interventions. Currently, the company operates remote monitoring programs in Portugal and France, and is expanding into Switzerland and Germany, with plans for a German launch in late 2026. In Romania, they are also establishing a local presence.
Hope Care claims its programs have led to significant clinical and economic benefits, including a reported 76% reduction in hospital days for chronic obstructive pulmonary disease patients, translating to substantial savings. As European healthcare systems grapple with chronic disease management, Hope Care is positioned as a key player, combining clinical evidence with regulatory compliance to enhance patient outcomes and the sustainability of healthcare delivery across the continent.